IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-05-07 (pharmvestnik.ru)
The costs of medicines in the United States increased by 11.4% in 2024 »Pharmacious tire
In 2024, the costs of drugs in the United States reached a record $ 487 billion. This is 11.4% more compared to a year earlier, the IQVIA research company reports.
Read more
2025-05-05 (fiercepharma.com)
US net drug spending surged 11.4% last year, boosted by obesity and oncology meds: IQVIA |
As sure as the sun rises, prescription medicine use and total drug spending continue to increase in the U.S. | Last year's $50 billion increase in net drug spending marked a period of "historic growth" that was only surpassed by 2021's COVID-19 vaccine launches, according to a new report from life sciences intelligence firm IQVIA.
Read more
2024-12-23 (pharmacyscanner.it)
Iqvia, closing of the year in break-even for the pharmacy which grows in 2023 only due to prices |
Last report of the year for the pharmacy market which - says Iqvia - is starting to close 2024 without
Read more
2024-02-05 (pressetext.com)
Growth of the drug market significantly slowed by price cuts
In 2023, the Swiss medicines market had a turnover of 7.4 billion francs, or +4.9% (at factory prices). Although demand for medicines increased, price reductions reduced growth by 2.7%.
Read more
2024-02-01 (managedhealthcareexecutive.com)
CMS Begins Medicare Drug Price Negotiations
New research finds that in 2022, U.S. prices across all drugs were almost three times higher than in other countries.
Read more
2021-03-01 (drugstorenews.com)
IQVIA report: U.S. health system is recovering from pandemic
U.S. medicine spending increased 0.8% on a net price basis to $359 billion, which reflects an increasing gap between list or invoice prices and manufacturer net revenues.
Read more